Pieter Van Wielendaele

6PUBLICATIONS
36CO-AUTHORS
Proteins and peptidesPredictive and prognostic markersGlycoconjugatesGenetically modified animalsChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 28, 2024
5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions.

Henri T Pätsi, Tommi P Kilpeläinen, Mikael Jumppanen

|Feb 25, 2023
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation.

Karen Claesen, Joni De Loose, Pieter Van Wielendaele

|Oct 23, 2021
The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors.

Alexandra De Zutter, Helena Crijns, Nele Berghmans

|Aug 28, 2021
The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples.

Stefan Magez, Zeng Li, Hang Thi Thu Nguyen

|Jun 02, 2021
The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.

Besa Emini Veseli, Pieter Van Wielendaele, Mirela Delibegovic

|Jul 04, 2020
Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).

Besa Emini Veseli, Paola Perrotta, Pieter Van Wielendaele

Pageof 1

Frequent Collaborators

3 joint publications

Ingrid De Meester

2 joint publications

Wim Martinet

2 joint publications

Guido R Y De Meyer

1 joint publications

Besa Emini Veseli